Brief: Pci Biotech Holding Q2 Net Loss Narrows To NOK 5.8 Mln

PCI Biotech Holding ASA

31/08/2023 06:15

Aug 31 (Reuters) - PCI Biotech Holding ASA  PCIB.OL :
    * CASH POSITION OF NOK 45 MILLION ENABLES A FINANCIAL RUNWAY TOWARDS END OF 2024 WITH
CURRENT
PLANS
    * WE HAVE SEEN PROMISING EARLY SIGNS OF ENHANCED DELIVERY OF NUCLEIC ACIDS FOR DERMATOLOGY
IN
SIMPLIFIED PRECLINICAL SETTINGS
    * BIOPROCESSING PROGRAM HAS MADE GOOD PROGRESS SINCE FIRST PATENT APPLICATION WAS FILED IN
2H 2022
    * WE CONTINUE TO PURSUE EXTERNAL FEEDBACK, BY SEEKING FIELD TESTING IN COLLABORATION WITH
POTENTIAL FUTURE CUSTOMERS
    * WILL FOCUS RESOURCES ON RESEARCH AND DEVELOPMENT.
    * Q2 NET LOSS NOK 5.8 MILLION VERSUS LOSS NOK 14.7 MILLION YEAR AGO

Source text for Eikon:  ID:nGNE6GchqZ 
Further company coverage:  PCIB.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))